2012 - Page 473 of 692 - 24/7 Wall St.

Paul Ausick | Mar 26, 2012 at 2:29 PM EDT

Teva Launches Generic Seroquel on First Day of Patent Loss (TEVA, AZN)

We noted earlier today that AstraZeneca plc (NYSE: AZN) had lost a patent ruling and that the company’s anti-pyschotic drug…

Paul Ausick | Mar 26, 2012 at 2:12 PM EDT

AudioCodes Dives on Lowered Outlook (AUDC)

Network gear maker AudioCodes Ltd. (NASDAQ: AUDC) lowered its first-quarter and full-year revenue and profit outlook this morning. From the…

Paul Ausick | Mar 26, 2012 at 1:44 PM EDT

Sinopec Profit Rises as Company Moves Upstream (SNP, CEO)

China Petroleum and Chemical Corp., commonly called Sinopec, (NYSE: SNP) reported a 2% profit gain for the 2011 fiscal year,…

Paul Ausick | Mar 26, 2012 at 1:26 PM EDT

US Supreme Court Appears Eager to Rule on Obamacare

After the first of three two-hour hearings, the US Supreme Court appears to be leaning toward issuing a ruling on…

Paul Ausick | Mar 26, 2012 at 1:08 PM EDT

Comverge Going Private (COMV)

Comverge Inc. (NASDAQ: COMV), a maker of intelligent control systems for electricity utilities and their customers, has agreed to be…

Paul Ausick | Mar 26, 2012 at 12:50 PM EDT

Coal Miner Lowers Profit Outlook (WLT)

Coal miner Walter Energy Inc. (NYSE: WLT) this morning lowered its revenue and profit forecasts for the current quarter, but,…

Paul Ausick | Mar 26, 2012 at 12:28 PM EDT

Intel Posts Gain in Semiconductor Market (INTC, ARMH, SSNLF, TXN, QCOM)

Intel Corp. (NASDAQ: INTC) grew its share of the total global semiconductor market to 15.9% in 2011, posting growth of…

Paul Ausick | Mar 26, 2012 at 12:04 PM EDT

Schlumberger Warns on Earnings (SLB, BHI, HAL)

ThinkstockAt an energy conference in New Orleans today, the CEO of Schlumberger Ltd. (NYSE: SLB) said that downward pressure on…

Paul Ausick | Mar 26, 2012 at 11:51 AM EDT

Sanofi, Regeneron Get Positive News from Drug Trials (SNY, REGN)

An anti-cholesterol drug being co-developed by Sanofi (NYSE: SNY) and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) has shown positive results in…

Paul Ausick | Mar 26, 2012 at 11:24 AM EDT

AT&T Nokia Launch Too Little, Too Late? (T, NOK, MSFT, AAPL, GOOG)

AT&T Inc. (NYSE: T) has set April 8th for the launch of the Lumia 900 smartphone from Nokia Corp. (NYSE:…

Paul Ausick | Mar 26, 2012 at 11:06 AM EDT

Texas Manufacturing Survey Steady

The Dallas Fed today released its report on Texas manufacturing, indicating that the activity level in February was equal to…

Paul Ausick | Mar 26, 2012 at 10:58 AM EDT

National Economic Activity Survey Down

The national activity index for the month of February fell to -0.09 from +0.33 in January according to today’s report…

Jon C. Ogg | Mar 26, 2012 at 10:55 AM EDT

The Stock Race to $1,000: Apple, Google, and Priceline (AAPL, GOOG, PCLN, BRK-A)

Many investors cannot mentally buy high-priced shares. It was not really an accident that Warren Buffett split the A and B…

Paul Ausick | Mar 26, 2012 at 10:42 AM EDT

Arena Files for European Drug Review (ARNA, VVUS, OREX)

Drug maker Arena Pharmaceuticals Inc. (NASDAQ: ARNA) announced that its application to sell its lorcaserin weight-loss drug in Europe has…

Jon C. Ogg | Mar 26, 2012 at 10:13 AM EDT

Pending Home Sales Still Look Rocky

Flickr, Images of MoneyWhat happened to all the reports about the bottom in the housing market? The number of pending…

1 … 471 472 473 474 475 … 692

Year: 2012

Teva Launches Generic Seroquel on First Day of Patent Loss (TEVA, AZN)

AudioCodes Dives on Lowered Outlook (AUDC)

Sinopec Profit Rises as Company Moves Upstream (SNP, CEO)

US Supreme Court Appears Eager to Rule on Obamacare

Comverge Going Private (COMV)

Coal Miner Lowers Profit Outlook (WLT)

Intel Posts Gain in Semiconductor Market (INTC, ARMH, SSNLF, TXN, QCOM)

Schlumberger Warns on Earnings (SLB, BHI, HAL)

Sanofi, Regeneron Get Positive News from Drug Trials (SNY, REGN)

AT&T Nokia Launch Too Little, Too Late? (T, NOK, MSFT, AAPL, GOOG)

Texas Manufacturing Survey Steady

National Economic Activity Survey Down

The Stock Race to $1,000: Apple, Google, and Priceline (AAPL, GOOG, PCLN, BRK-A)

Arena Files for European Drug Review (ARNA, VVUS, OREX)

Pending Home Sales Still Look Rocky

SMCZ vs. SMCX: Betting Against or All-In on Super Micro?

$3,500 in CD Interest Was Enough to Drag 85% of a 72-Year-Old’s Social Security Into the Taxable Zone

Forget Micron: 1 Record-Breaking Cloud Powerhouse to Buy Hand Over Fist After the Pullback

$3,500 in CD Interest Was Enough to Drag 85% of a 72-Year-Old's Social Security Into the Taxable Zone

Roth Conversions Between 62 and 70: The $600,000 Tax Hack That Could Save You Tens of Thousands

SMCZ vs. SMCX: Betting Against or All-In on Super Micro?

$3,500 in CD Interest Was Enough to Drag 85% of a 72-Year-Old’s Social Security Into the Taxable Zone

Teva Launches Generic Seroquel on First Day of Patent Loss (TEVA, AZN)

AudioCodes Dives on Lowered Outlook (AUDC)

Sinopec Profit Rises as Company Moves Upstream (SNP, CEO)

US Supreme Court Appears Eager to Rule on Obamacare

Comverge Going Private (COMV)

Coal Miner Lowers Profit Outlook (WLT)

Intel Posts Gain in Semiconductor Market (INTC, ARMH, SSNLF, TXN, QCOM)

Schlumberger Warns on Earnings (SLB, BHI, HAL)

Sanofi, Regeneron Get Positive News from Drug Trials (SNY, REGN)

AT&T Nokia Launch Too Little, Too Late? (T, NOK, MSFT, AAPL, GOOG)

Texas Manufacturing Survey Steady

National Economic Activity Survey Down

The Stock Race to $1,000: Apple, Google, and Priceline (AAPL, GOOG, PCLN, BRK-A)

Arena Files for European Drug Review (ARNA, VVUS, OREX)

Pending Home Sales Still Look Rocky

SMCZ vs. SMCX: Betting Against or All-In on Super Micro?

$3,500 in CD Interest Was Enough to Drag 85% of a 72-Year-Old’s Social Security Into the Taxable Zone

Forget Micron: 1 Record-Breaking Cloud Powerhouse to Buy Hand Over Fist After the Pullback

Featured Reads

$3,500 in CD Interest Was Enough to Drag 85% of a 72-Year-Old's Social Security Into the Taxable Zone

Roth Conversions Between 62 and 70: The $600,000 Tax Hack That Could Save You Tens of Thousands